NCT07617467 Group-based ACT for Psychological Distress of Young People
| NCT ID | NCT07617467 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sorlandet Hospital HF |
| Condition | Depression - Major Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 212 participants |
| Start Date | 2026-03-09 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 212 participants in total. It began in 2026-03-09 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical study investigates the effectiveness of two psychological treatment formats for young people aged 16-25 with symptoms of depression, anxiety, stress, or interpersonal difficulties. The study compares group-based Acceptance and Commitment Therapy (ACT) with treatment as usual (TAU), most frequent that would be individual psychotherapy, both of which are established treatment approaches. The study uses a randomized controlled design (RCT), in which participants are randomly assigned to one of the two treatment conditions. This allows for a systematic comparison of treatment outcomes between ACT delivered in a group format and standard individual therapy. The ACT group intervention consists of a structured program in which participants meet regularly over a defined treatment period. The treatment focuses on processes such as psychological flexibility, acceptance of internal experiences, and engagement in actions aligned with personal values. The individual therapy condition consists of one-to-one sessions with a clinician, following standard therapeutic practice. Treatment content and duration are tailored to the participant's clinical presentation and therapeutic needs. Outcome measures include standardized assessments of mental health symptoms, functioning, and psychological processes. These assessments are conducted at baseline, during the treatment period, at post-treatment, and at follow-up time points. Data collected from these measures will be used to evaluate changes over time and differences between the two treatment conditions. The primary aim of the study is to determine whether group-based ACT is as effective as, or more effective than, individual psychotherapy for young people receiving mental health services. The results are expected to contribute to improved knowledge about treatment options for this age group and inform future clinical practice.
Eligibility Criteria
Inclusion Criteria: * Score on DASS-21 depression scale ≤ 14 Exclusion Criteria: * Psychosis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07617467 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 25 Years, studying Depression - Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07617467 currently recruiting?
Yes, NCT07617467 is actively recruiting participants. Contact the research team at vegard.oksendal.haaland@sshf.no for enrollment information.
Where is the NCT07617467 trial being conducted?
This trial is being conducted at Arendal, Norway, Kristiansand, Norway.
Who is sponsoring the NCT07617467 clinical trial?
NCT07617467 is sponsored by Sorlandet Hospital HF. The trial plans to enroll 212 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.